GlassScriptPhysician profile
Robin A Hugen
NPI 1285668335
$1,310.94
in general payments reported to CMS, 2019-2025
20 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $86.25 · 2021: $118 · 2022: $305 · 2023: $169 · 2024: $162 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $333.02 | 2019-2025 | |
| Ironshore Pharmaceuticals INC. | $229.55 | 2019-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $127.85 | 2019-2023 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Supernus Pharmaceuticals, INC. | $75.04 | 2022-2025 | Qelbree, Qelbree |
| Sobi, INC | $71.57 | 2019-2024 | |
| Kaleo, INC. | $70.29 | 2019-2023 | Auvi-Q |
| Tris Pharma INC | $59.19 | 2019-2020 | |
| Sanofi Pasteur INC. | $41.16 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.35 | 2021-2022 | |
| Ars Pharmaceuticals Operations, INC. | $38.16 | 2025 | Neffy |
| Alk-Abello, INC | $34.69 | 2025 | Neffy, Odactra, Ragwitek |
| Genentech USA, INC. | $34.58 | 2021-2022 | |
| Cranial Technologies, INC | $32.33 | 2019-2023 | Doc Band |
| Vertical Pharmaceuticals, LLC | $20.39 | 2019 | |
| Photonicare INC | $18.96 | 2025 | Otosight Middle Ear Scope |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $18.39 | 2025 | |
| Oxford Immunotec USA INC | $17.83 | 2020 | |
| Seqirus USA INC | $17.33 | 2022 | |
| Adlon Therapeutics L.P. | $16.23 | 2019 | |
| Phadia US INC. | $15.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Hugen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.